Not applicableUnknownNCT03753308What this trial is testingMechanism of DCs Dysfunction in Chronic HBV InfectionWho this might be right forHBVNASH - Nonalcoholic Steatohepatitis University Hospital, Grenoble 132
Early research (Phase 1)Study completedNCT02070549What this trial is testingTrametinib in Treating Patients With Advanced Cancer With or Without Hepatic DysfunctionWho this might be right forAdvanced Malignant Solid NeoplasmMetastatic Malignant Neoplasm in the LiverMetastatic Malignant Solid Neoplasm+1 more National Cancer Institute (NCI) 46
Not applicableStudy completedNCT01439854What this trial is testingStudy of Dapagliflozin on Mitochondrial Dysfunction and Impaired Insulin Signaling/ActionWho this might be right forInsulin SensitivityMultiple Mitochondrial Dysfunctions Syndrome The University of Texas Health Science Center at San Antonio 18
Post-approval studies (Phase 4)Active Not RecruitingNCT05493761What this trial is testingEffect of Anti-osteoporotic Medications on Nonalcoholic Fatty Liver DiseaseWho this might be right forNonalcoholic Fatty LiverOsteoporosis, Postmenopausal Aristotle University Of Thessaloniki 72
Not applicableLooking for participantsNCT07439939What this trial is testingExploration of Systemic and Portal Hemostasis in Patients Undergoing Transjugular Intrahepatic Portosystemic Shunt PlacementWho this might be right forLiver CirrhosisPortal Hypertension Assistance Publique - Hôpitaux de Paris 45
Not applicableLooking for participantsNCT06431919What this trial is testingCarvedilol + Simvastatin vs. Carvedilol Alone for Cirrhosis and Cirrhotic Cardiomyopathy and Impact on Hepatic Decompensation and SurvivalWho this might be right forDecompensated CirrhosisCirrhotic CardiomyopathyCirrhosis, Liver+2 more Post Graduate Institute of Medical Education and Research, Chandigarh 260
Not applicableStudy completedNCT07304336What this trial is testingDietary Strategies for MASLD (Metabolic Dysfunction-Associated Steatotic Liver Disease)Who this might be right forMASLD University of Turin, Italy 173
Testing effectiveness (Phase 2)Study completedNCT00867698What this trial is testingAST-120 Used to Treat Mild Hepatic EncephalopathyWho this might be right forMild Hepatic Encephalopathy Ocera Therapeutics 148
Not applicableUnknownNCT02850692What this trial is testingPortal Hypertension and Systemic Endothelial FunctionWho this might be right forCystic FibrosisPortal Hypertension Hopital Foch 60
Not applicableLooking for participantsNCT07343037What this trial is testingDiagnosis of Lymphohistiocytic Hemophagocytosis in Intensive CareWho this might be right forHepatic InsufficiencyCirrhosis, Liver University Hospital, Strasbourg, France 100
Not applicableLooking for participantsNCT07454824What this trial is testingE-ALIGN: A Patient Portal-based Intervention to Align Medications With What Matters MostWho this might be right forDementiaPotentially Inappropriate Medication UseMild Cognitive Impairment (MCI) Johns Hopkins University 100
Large-scale testing (Phase 3)Looking for participantsNCT06461208What this trial is testingA PROspective Faecal MIcrobiota tranSplantation Trial to Improve outcomEs in Patients With CirrhosisWho this might be right forLiver Cirrhosis King's College London 300
Not applicableLooking for participantsNCT07412444What this trial is testingEVOO and Metabolic Liver Health in MASLDWho this might be right forMASLD - Metabolic Dysfunction-Associated Steatotic Liver DiseaseOverweight Azienda Ospedaliera Specializzata in Gastroenterologia Saverio de Bellis 60
Early research (Phase 1)Study completedNCT00047346What this trial is testingErlotinib in Treating Patients With Unresectable Liver Cancer and Liver DysfunctionWho this might be right forAdult Primary Hepatocellular CarcinomaAdvanced Adult Primary Liver CancerLocalized Unresectable Adult Primary Liver Cancer+1 more National Cancer Institute (NCI) 24
Large-scale testing (Phase 3)Looking for participantsNCT07165028What this trial is testingA Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)Who this might be right forMetabolic Dysfunction-Associated Steatotic Liver Disease Eli Lilly and Company 4,500
Early research (Phase 1)UnknownNCT05195125What this trial is testingUse of Direct Peritoneal Resuscitation in High-risk Liver Transplant RecipientsWho this might be right forEnd Stage Liver DIseaseObesityAcute Kidney Injury University of Colorado, Denver 15
Not applicableStudy completedNCT03586115What this trial is testingMinimal Hepatic Encephalopathy in Hereditary Hemorrhagic TelangiectasianWho this might be right forHepatic EncephalopathyMinimal Brain Dysfunction University of Bari 50
Post-approval studies (Phase 4)Active Not RecruitingNCT05031026What this trial is testingDexmedetomidine to Prevent Hepatic Ischemia-reperfusion Injury-induced Glycocalyx Degradation and Early Allograft Dysfunction in Liver TransplantationWho this might be right forLiver Transplant; Complications Assiut University 60
Not applicableNot Yet RecruitingNCT07475962What this trial is testingPrevalence and Risk Factors of Metabolic-Associated Hepatic Steatosis in Individuals Living With Type 1 DiabetesWho this might be right forType 1 DiabetesLiver SteatosesMASLD - Metabolic Dysfunction-Associated Steatotic Liver Disease+2 more Institut de Recherches Cliniques de Montreal 100
Not applicableStudy completedNCT07182136What this trial is testingThe Impact of Hepatic Steatosis on Survival After PancreaticoduodenectomyWho this might be right forNonalcoholic Fatty Liver Disease After Pancreaticoduodenectomy Wei-Hsun Lu 200